Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Clinical Center, Clinical Center
CONTACT
Lead
Aptabio Therapeutics, Inc.
Part A will be a randomized, double-blind, placebo-controlled, single ascending dose (SAD) study in healthy participants. Part B will be a randomized, double-blind, placebo-controlled, multiple ascending doses (MAD) study in healthy participants. Part C will be an open-label study in participants with AMD. For Part A and B, serial blood samples will be collected to assess the PK of ABF-101. Ocular examinations will be conducted to evaluate changes in ocular characteristics and function.
Age
18–50
Sex
ALL
Healthy volunteers
Accepted
